• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ORXOF:US

16.6400 USD 0.9100 5.19%

As of 20:10:07 ET on 12/09/2014.

Snapshot for Orexo AB (ORXOF)

Open: 16.6400 Day's Range: 16.6400 - 16.6400 Volume: 425
Previous Close: 17.5500 52wk Range: 14.0400 - 25.8000 1-Yr Rtn: -

Stock Chart for ORXOF

No chart data available.
  • ORXOF:US 16.6400
  • 1D
  • 1M
  • 1Y
17.5500
Interactive ORXOF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ORXOF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (SEK) (ttm) -
Est. EPS (SEK) (12/2014) -3.1590
Est. PEG Ratio -
Market Cap (M USD) 571.51
Shares Outstanding (M) 34.35
30 Day Average Volume 39
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 01/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ORXOF

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for ORXOF

Orexo AB is a product oriented drug delivery company that develops new pharmaceuticals by further develop existing products. The Company specializes in drugs in tablet form especially sublingual pills and often works together with scientists and other corporations. Orexo sells internationally.

Martin NicklassonChairmanNikolaj SoerensenChief Executive Officer
Jesper LindChief Operating OfficerPeter EdmanChief Scientific Officer
More Company Profile & Key Executives for ORXOF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
  • ORXOF News

  • Industry News

Advertisement
Sponsored Links
Advertisements
sec ||= nil